The discovery of a novel series of compounds with single-dose efficacy against juvenile and adult Schistosoma species.
Treatment and control of schistosomiasis depends on a single drug, praziquantel, but this is not ideal for several reasons including lack of potency against the juvenile stage of the parasite, dose size, and risk of resistance. We have optimised the properties of a series of compounds we discovered...
Saved in:
| Main Authors: | J Mark F Gardner, Nuha R Mansour, Andrew S Bell, Helena Helmby, Quentin Bickle |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-07-01
|
| Series: | PLoS Neglected Tropical Diseases |
| Online Access: | https://doi.org/10.1371/journal.pntd.0009490 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High Throughput Screening Identifies Novel Lead Compounds with Activity against Larval, Juvenile and Adult Schistosoma mansoni.
by: Nuha R Mansour, et al.
Published: (2016-04-01) -
Discovery of clocinizine as a potential oral drug against Schistosoma mansoni infection
by: Thalitta Castro, et al.
Published: (2025-08-01) -
Genomic evidence of contemporary hybridization between Schistosoma species.
by: Duncan J Berger, et al.
Published: (2022-08-01) -
Optimizing the therapeutic benefits of synriam combined with praziquantel in mice harbouring juvenile and mature Schistosoma mansoni
by: Abdel-Nasser A. Sabra, et al.
Published: (2025-08-01) -
Efficacy of single dose praziquantel against Schistosoma mansoni in East Africa: a systematic review and meta-analysis
by: Miseganaw Sisay, et al.
Published: (2025-02-01)